{
  "trial_id": "NCT03790384",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "centrally randomized",
      "label": "met",
      "evidence": "Methods: A consecutive series of patients with High Risk Non-Muscle Invasive Bladder Cancer will be enrolled in several centres"
    },
    {
      "criterion": "BCG induction treatment",
      "label": "met",
      "evidence": "Patients selected for the study, are centrally randomized (randomization is performed at the Sant'Andrea Hospital) to receive BCG induction treatment according to the standard protocol"
    },
    {
      "criterion": "High Risk Non-Muscle Invasive Bladder Cancer",
      "label": "met",
      "evidence": "Clinical evaluation: Patients with High Risk Non-Muscle Invasive Bladder Cancer will be enrolled"
    }
  ],
  "exclusion": [
    {
      "criterion": "Low Risk Non-Muscle Invasive Bladder Cancer",
      "label": "triggers",
      "evidence": ""
    },
    {
      "criterion": "Muscle Invasive Bladder Cancer",
      "label": "triggers",
      "evidence": ""
    }
  ],
  "notes": "The patient is a 25-year-old pregnant woman with symptoms of fever, chills, nausea, vomiting, dysuria, urgency, and frequency. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease.",
  "_meta": {
    "topic_id": "51",
    "trial_id": "NCT03790384",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}